1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
FEATURED COMPANIES
- 3Brain AG
- Axion BioSystems Inc.
- Harvard Bioscience Inc.
- MaxWell Biosystems AG
- Neuralynx Inc.
- Neuronexus
1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
Global In-Vitro And In-Vivo Micro Electrode Array Market 2020-2024
The in-vitro and in-vivo micro electrode array market is poised to grow by $ 5.49 mn during 2020-2024, progressing at a CAGR of 4% during the forecast period. The report on the in-vitro and in-vivo micro electrode array market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the extensive use of MEAs in neuroscience research, wide applications of in vitro CMOS-based MEAs, and the advent of 3D nanoparticle printing technology. In addition, Extensive use of MEAs in neuroscience research is anticipated to boost the growth of the market as well.
The in-vitro and in-vivo micro electrode array market analysis includes end-user segment, type segment, and geographical landscapes.
The in-vitro and in-vivo micro electrode array market is segmented as below:
By End-user
By Type
By Geographical Landscapes
This study identifies the potential application in cancer tissue detection as one of the prime reasons driving the in-vitro and in-vivo micro electrode array market growth during the next few years. Also, the increasing need for R&D owing to the rising incidence of pandemic diseases and the emergence of neurostimulation devices will lead to sizable demand in the market.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The report on the in-vitro and in-vivo micro electrode array market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading in-vitro and in-vivo micro electrode array market vendors that include 3Brain AG, Axion BioSystems Inc., Blackrock Microsystems LLC, Harvard Bioscience Inc., MaxWell Biosystems AG, Neuralynx Inc., Neuronexus, Plexon Inc., Screen Holdings Co. Ltd., and Tucker Davis Technologies. Also, the in-vitro and in-vivo micro electrode array market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
The in-vitro and in-vivo micro electrode array market is poised to grow by $ 5.49 mn during 2020-2024, progressing at a CAGR of 4% during the forecast period. The report on the in-vitro and in-vivo micro electrode array market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the extensive use of MEAs in neuroscience research, wide applications of in vitro CMOS-based MEAs, and the advent of 3D nanoparticle printing technology. In addition, Extensive use of MEAs in neuroscience research is anticipated to boost the growth of the market as well.
The in-vitro and in-vivo micro electrode array market analysis includes end-user segment, type segment, and geographical landscapes.
The in-vitro and in-vivo micro electrode array market is segmented as below:
By End-user
- Industrial labs and CROs
- Academic, govt, and other research labs
By Type
- Multiwell MEA
- Single well MEA
By Geographical Landscapes
- North America
- Europe
- Asia
- ROW
This study identifies the potential application in cancer tissue detection as one of the prime reasons driving the in-vitro and in-vivo micro electrode array market growth during the next few years. Also, the increasing need for R&D owing to the rising incidence of pandemic diseases and the emergence of neurostimulation devices will lead to sizable demand in the market.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The report on the in-vitro and in-vivo micro electrode array market covers the following areas:
- In-vitro and in-vivo micro electrode array market sizing
- In-vitro and in-vivo micro electrode array market forecast
- In-vitro and in-vivo micro electrode array market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading in-vitro and in-vivo micro electrode array market vendors that include 3Brain AG, Axion BioSystems Inc., Blackrock Microsystems LLC, Harvard Bioscience Inc., MaxWell Biosystems AG, Neuralynx Inc., Neuronexus, Plexon Inc., Screen Holdings Co. Ltd., and Tucker Davis Technologies. Also, the in-vitro and in-vivo micro electrode array market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary.
This market research report provides a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- 3Brain AG
- Axion BioSystems Inc.
- Harvard Bioscience Inc.
- MaxWell Biosystems AG
- Neuralynx Inc.
- Neuronexus
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by End-user
Market Segmentation by Type
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
List of Exhibits
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- 3Brain AG
- Axion BioSystems Inc.
- Harvard Bioscience Inc.
- MaxWell Biosystems AG
- Neuralynx Inc.
- Neuronexus
The publisher recognizes the following companies as the key players in the global in-vitro and in-vivo micro electrode array market: 3Brain AG, Axion BioSystems Inc., Blackrock Microsystems LLC, Harvard Bioscience Inc., MaxWell Biosystems AG, Neuralynx Inc., Neuronexus, Plexon Inc., Screen Holdings Co. Ltd., and Tucker Davis Technologies.
Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is potential application in cancer tissue detection."
According to the report, one of the major drivers for this market is the extensive use of meas in neuroscience research.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is potential application in cancer tissue detection."
According to the report, one of the major drivers for this market is the extensive use of meas in neuroscience research.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
A selection of companies mentioned in this report includes:
- 3Brain AG
- Axion BioSystems Inc.
- Blackrock Microsystems LLC
- Harvard Bioscience Inc.
- MaxWell Biosystems AG
- Neuralynx Inc.
- Neuronexus
- Plexon Inc.
- Screen Holdings Co. Ltd.
- Tucker Davis Technologies
Note: Product cover images may vary from those shown
![Medical Electrodes Market by Product [Diagnostic Electrodes (ECG, EEG, EMG), Therapeutic Electrodes (Defibrillator, Pacemaker)], Technology (Wet, Dry, Needle), Application (Neurophysiology, IOM), Usage (Disposable, Reusable), - Global Forecast to 2026 - Product Image](http://www.researchandmarkets.com/product_images/11390/11390144_60px_jpg/medical_electrodes_market.jpg)
